Panacea Acquisition Corp. II (PANA)
| Market Cap | 239.22M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -100,673 |
| Shares Out | 23.55M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 365,546 |
| Open | 10.17 |
| Previous Close | 10.18 |
| Day's Range | 10.16 - 10.18 |
| 52-Week Range | 9.69 - 10.87 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PANA
Panacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California. [Read more]
Financial Performance
Financial StatementsNews
Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering
SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisitio...
Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio
SAN FRANCISCO--(BUSINESS WIRE)--Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 3...
4 SPAC Mergers: What The KBLM, ACAM, PANA And SMMC Deals Mean For Investors
Last week saw continued momentum in special purpose acquisition company (SPAC) mergers, as KBL Merger (NASDAQ: KBLM), Acamar Partners Acquisition Corp. (NASDAQ: ACAM), Panacea Acquisition Corp. (NYSE:...